A 52-year-old man was newly diagnosed with Philadelphia chromosome–positive Chronic Myeloid Leukemia in chronic phase (CML-CP) during routine evaluation for fatigue and persistent leukocytosis. BCR::ABL1 testing confirmed active molecular disease, necessitating initiation of first-line tyrosine kinase inhibitor therapy, with emphasis on long-term e
25 Reached
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
Vildagliptin in Reducing Risk of Post-partum Diabetes
2386 Reached7 Comments4 Likes